HIV-positive people who do not develop AIDS and do not require antiretroviral medication could provide insight for new strategies in vaccine development, according to a study published Sunday in the journal Nature, London's Independent reports. Michel Nussenzweig -- head of Rockefeller University's Laboratory of Molecular Immunology and author of the study -- said his research aimed to harness natural mechanisms to target HIV rather than use synthetically produced antibodies, some of which have failed in earlier HIV vaccine trials.
Read the rest on the Kaiser Daily HIV/AIDS report.
No comments:
Post a Comment